10x Genomics Stock Forecast
NASDAQ: TXGIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
Market open · Delayed 15 min · as of Oct 8, 3:19 PM ET
TXG analyst consensus
Consensus (19 analysts)
buy
Avg. price target
$66.00-12.88%
- Strong buy 1
- Buy 6
- Hold 12
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 19 Wall Street analysts covering 10x Genomics (2026-10-07), 7 rate the stock a buy or strong buy, 12 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $66.00, with a high estimate of $110.00 and a low estimate of $40.00. The average target implies downside of 12.9% from the current price of $75.76.
The spread between the highest and lowest targets is 175.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for TXG.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 5% |
| Buy | 6 | 32% |
| Hold | 12 | 63% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $40.00 | -47.20% |
| Average target | $66.00 | -12.88% |
| High target | $110.00 | +45.20% |